Amdocs (NASDAQ:DOX) Hits New 1-Year Low – Time to Sell?

Shares of Amdocs Limited (NASDAQ:DOX) hit a new 52-week low on Tuesday . The company traded as low as $66.53 and last traded at $67.4310, with a volume of 870139 shares trading hands. The stock had previously closed at $69.23.

Analyst Ratings Changes

A number of brokerages have commented on DOX. Stifel Nicolaus decreased their price objective on Amdocs from $97.00 to $88.00 and set a “buy” rating for the company in a research report on Wednesday, February 4th. Weiss Ratings restated a “hold (c)” rating on shares of Amdocs in a report on Tuesday, January 27th. Wall Street Zen raised shares of Amdocs from a “hold” rating to a “buy” rating in a research report on Saturday, February 7th. Barclays cut their target price on shares of Amdocs from $111.00 to $92.00 and set an “overweight” rating for the company in a research report on Wednesday, February 4th. Finally, Bank of America lowered their price target on shares of Amdocs from $100.00 to $97.00 and set a “buy” rating on the stock in a report on Wednesday, November 12th. Three analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $92.33.

Amdocs Stock Performance

The stock has a fifty day moving average price of $78.97 and a 200 day moving average price of $81.33. The company has a current ratio of 1.06, a quick ratio of 1.17 and a debt-to-equity ratio of 0.23. The firm has a market cap of $7.54 billion, a price-to-earnings ratio of 13.50, a price-to-earnings-growth ratio of 1.25 and a beta of 0.40.

Amdocs (NASDAQ:DOX) last posted its earnings results on Tuesday, February 3rd. The technology company reported $1.81 earnings per share for the quarter, topping the consensus estimate of $1.75 by $0.06. Amdocs had a return on equity of 20.19% and a net margin of 12.47%.The firm had revenue of $1.16 billion during the quarter, compared to analyst estimates of $1.15 billion. During the same period in the previous year, the company earned $1.66 EPS. The company’s revenue for the quarter was up 4.1% on a year-over-year basis. Amdocs has set its Q2 2026 guidance at 1.730-1.790 EPS and its FY 2026 guidance at 7.270-7.550 EPS. As a group, analysts predict that Amdocs Limited will post 6.21 earnings per share for the current year.

Amdocs Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, April 24th. Investors of record on Tuesday, March 31st will be issued a $0.569 dividend. This is a boost from Amdocs’s previous quarterly dividend of $0.53. The ex-dividend date is Tuesday, March 31st. This represents a $2.28 annualized dividend and a yield of 3.3%. Amdocs’s payout ratio is 40.81%.

Institutional Trading of Amdocs

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in DOX. EP Wealth Advisors LLC bought a new stake in shares of Amdocs in the fourth quarter valued at approximately $631,000. Mackenzie Financial Corp increased its position in Amdocs by 218.0% during the fourth quarter. Mackenzie Financial Corp now owns 118,898 shares of the technology company’s stock worth $9,644,000 after acquiring an additional 81,504 shares during the period. NewEdge Advisors LLC raised its stake in Amdocs by 8.6% during the 4th quarter. NewEdge Advisors LLC now owns 11,276 shares of the technology company’s stock valued at $908,000 after purchasing an additional 897 shares during the last quarter. Empowered Funds LLC boosted its holdings in Amdocs by 97.4% in the 4th quarter. Empowered Funds LLC now owns 41,466 shares of the technology company’s stock valued at $3,338,000 after purchasing an additional 20,460 shares during the period. Finally, XTX Topco Ltd grew its position in Amdocs by 41.2% in the 4th quarter. XTX Topco Ltd now owns 14,183 shares of the technology company’s stock worth $1,142,000 after purchasing an additional 4,139 shares during the last quarter. Institutional investors and hedge funds own 92.02% of the company’s stock.

About Amdocs

Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.

Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.